Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases Results of a lower dosage and shorter interval regimen

Saved in:
Bibliographic Details
Published in:Scandinavian journal of rheumatology 2014-01, Vol.43 (3), p.257-258
Main Authors: Moazedi-Fuerst, FC, Kielhauser, SM, Brickmann, K, Hermann, J, Lutfi, A, Meilinger, M, Brezinschek, HP, Graninger, WB
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Murine-Derived - administration & dosage
Antibodies, Monoclonal, Murine-Derived - adverse effects
Disease Progression
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Letter
Male
Pulmonary Fibrosis - drug therapy
Pulmonary Fibrosis - etiology
Risk Assessment
Rituximab
Scleroderma, Systemic - complications
Scleroderma, Systemic - diagnosis
Scleroderma, Systemic - drug therapy
Severity of Illness Index
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0300-9742
1502-7732
DOI:10.3109/03009742.2013.869617